Pyrogen Testing Market Overview and Introduction

Global Pyrogen Testing Market is estimated to be over US$ 650 Million in 2018. It is anticipated to grow at a 11.0% CAGR from 2019 to 2030.

Pyrogen is a substance that induces fever, once the drug has been administered in the body. The presence of a pyrogenic element in a drug composition is undesirable. Hence, certain tests are carried out to check whether a particular drug can cause the undesirable side-effect in the body. The endotoxins, which are secreted by bacteria, possess the ability to elevate the body temperature.

The emergence of new pharmaceutical companies across major economies of the world provides a major boost to the pyrogen testing market. Moreover, as per the regulations laid down by the Food and Drug Administration (FDA), it is mandatory for every pharmaceutical company to undergo pyrogen testing. So this obligation further propels the market revenue. However, high consolidation of pharmaceutical industries acts as a setback for the market.

Pyrogen Testing Market by Product, Test Type and End User

Based on the product, the market is classified into instruments, kits and reagents, and services. A major share of the market revenue is represented by the sales of kits and reagents. The reason can be attributed to adoption and focus on kit-based technology.

Pyrogen Testing Market by Test Type

Based on the test type, the market is divided into In Vitro tests, Limulus Amebocyte Lysate (LAL) tests, and rabbit tests. The LAL test is further sub-segmented into gel clot tests, turbidimetric tests, and chromogenic tests. The LAL test is widely preferred by pharmaceutical industries, especially in India and China.

Pyrogen Testing Market by End User

In terms of end user, the market is categorized into pharmaceutical companies, biotechnology companies, medical device companies, food & beverage companies, and cosmetic companies. The pharmaceutical companies are likely to account for largest share in the market.

Pyrogen Testing Market by Region

The pyrogen testing market can be segmented into North America, Europe, Asia Pacific, and Rest of World (ROW). In North America, the U.S. accounted for the largest share. High penetration and acceptance of the technology are likely to spur the sales in this region, as well as developed economy and stringent regulations laid down by the FDA in the North American region are likely to bolster the pyrogen testing market. European countries like Germany is likely to account for the largest share in the region. The Asia Pacific region is anticipated to register highest CAGR of the pyrogen testing market during the forecast period owing to, rising number of diseases and infection in countries like India and China.

Pyrogen Testing Market Prominent Players

The prominent players in the pyrogen testing market are Charles River, Inc., Ellab A/S Inc., Lonza, Ltd., Merck KGaA, Inc., Associates of Cape Cod Inc., GenScript, Inc., Wako, Inc., Sanquin Inc., bioMerieux SA, Inc., and WuXi PharmaTech (Cayman), Inc.